Neurocrine Biosciences (NBIX) Market Capitalization (2009 - 2026)
Neurocrine Biosciences' Market Capitalization came in at $14.37 billion for Q3 2026, up 2.7% from $14 billion a year earlier but down 16.1% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Market Capitalization (2009 - 2026) Analysis & Trends
For FY2025, Neurocrine Biosciences' Market Capitalization was $14.2 billion, up 4.6% from FY2024.
- Market Capitalization has increased in each of the last four years, with a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $13.57 billion in FY2024 (+4.3%), $13 billion in FY2023 (+12.8%), $11.53 billion in FY2022 (+42.6%) and $8.08 billion in FY2021 (-9.8%).
- The five-year range for quarterly Market Capitalization is $8.08 billion (Q4 2021) to $17.12 billion (Q2 2026).
- Year-over-year, Market Capitalization has increased for five consecutive quarters, with growth averaging 7.4% over the last eight quarters.
- The fastest year-over-year change in Market Capitalization over five years came in Q2 2024 (growth of 50.9%), and the weakest in Q1 2025 (a decline of 21.1%).
- Business Quant data shows NBIX's Market Capitalization at $17.12 billion (Q2 2026), $13.25 billion (Q1 2026) and $14.2 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.37 Bn |
| Jun 30, 2026 | 17.12 Bn |
| Mar 31, 2026 | 13.25 Bn |
| Dec 31, 2025 | 14.20 Bn |
| Sep 30, 2025 | 14.00 Bn |
| Jun 30, 2025 | 12.44 Bn |
| Mar 31, 2025 | 10.95 Bn |
| Dec 31, 2024 | 13.57 Bn |
| Sep 30, 2024 | 11.66 Bn |
| Jun 30, 2024 | 13.89 Bn |
| Mar 31, 2024 | 13.87 Bn |
| Dec 31, 2023 | 13.00 Bn |
| Sep 30, 2023 | 11.05 Bn |
| Jun 30, 2023 | 9.20 Bn |
| Mar 31, 2023 | 9.87 Bn |
| Dec 31, 2022 | 11.53 Bn |
| Sep 30, 2022 | 10.21 Bn |
| Jun 30, 2022 | 9.32 Bn |
| Mar 31, 2022 | 8.95 Bn |
| Dec 31, 2021 | 8.08 Bn |
API Access
Neurocrine Biosciences Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();